Companies / Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc.
TPTXCIK 1595893
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | George Simeon Director | Other Sold to issuer | Common Stock | $171.28M | -2.3M -100.00% | 0 | low |
| Aug 17, 2022 | Countouriotis Athena CEO | Other Sold to issuer | Common Stock | $8.43M | -111K -100.00% | 0 | low |
| Aug 17, 2022 | Sun Brian Executive | Other Sold to issuer | Common Stock | $3.42M | -45K -100.00% | 0 | low |
| Aug 17, 2022 | Hirmand Mohammad Executive | Other Sold to issuer | Common Stock | $3.14M | -41K -100.00% | 0 | low |
| Aug 17, 2022 | Sabus Steve M Executive | Other Sold to issuer | Common Stock | $2.79M | -37K -100.00% | 0 | low |
| Jan 7, 2021 | Baker Brian Lee Executive | Sell Open-market sale | Common Stock | $2.67M | -22K -93.48% | 1,521 | medium |
| Feb 10, 2021 | Countouriotis Athena CEO | Sell Open-market sale | Common Stock | $2.27M | -17K -23.98% | 52,709 | medium |
| Aug 17, 2022 | Tombesi Paolo Executive | Other Sold to issuer | Common Stock | $2.26M | -30K -100.00% | 0 | low |